Skip to main navigation Skip to search Skip to main content

Erratum: The use of ultrasensitive quantitative-PCR to assess the impact of primaquine on asymptomatic relapse of Plasmodium vivax infections: A randomized, controlled trial in Lao PDR

  • K. Phommasone
  • , F. Van Leth
  • , M. Imwong
  • , G. Henriques
  • , T. Pongvongsa
  • , B. Adhikari
  • , T.J. Peto
  • , C. Promnarate
  • , M. Dhorda
  • , P. Sirithiranont
  • , M. Mukaka
  • , P. Peerawaranun
  • , N.P.J. Day
  • , F. Cobelens
  • , A.M. Dondorp
  • , P.N. Newton
  • , N.J. White
  • , L. Von Seidlein
  • , M. Mayxay

Research output: Contribution to Journal › Erratum / Corrigendum › Academic

Abstract

Reference: Following publication of the original article [1], it was brought to the authors' attention that one of the names in the author list had been provided with the incorrect spelling. Namely, Mehul Dhorda had been incorrectly spelled as Mehul Dorda. The error has since been corrected in the original article. The authors apologize for any inconvenience caused.
Original languageEnglish
Article number32
Number of pages1
JournalMalaria Journal
Volume19
Issue number1
Early online date21 Jan 2020
DOIs
Publication statusPublished - Dec 2020
Externally publishedYes

Bibliographical note

Erratum: The use of ultrasensitive quantitative-PCR to assess the impact of primaquine on asymptomatic relapse of Plasmodium vivax infections: A randomized, controlled trial in Lao PDR (Malaria Journal (2020) 19 (4) DOI: 10.1186/s12936-019-3091-5)

Funding

FundersFunder number
???publication-publication-funding-organisation-not-added???10223
Wellcome Trust101148

    Fingerprint

    Dive into the research topics of 'Erratum: The use of ultrasensitive quantitative-PCR to assess the impact of primaquine on asymptomatic relapse of Plasmodium vivax infections: A randomized, controlled trial in Lao PDR'. Together they form a unique fingerprint.

    Cite this